GE HealthCare invests $160 million in Laza Medical's AI-powered cath lab robotics
Overview
GE HealthCare led a $160 million financing round for Laza Medical, a startup developing an AI-powered robotic transesophageal echo (TEE) system for interventional cardiology. The investment will support development of the system designed to simplify procedures, increase autonomy, and improve access to therapies. The technology combines real-time 3D heart modeling, procedural guidance, and robotic probe control for structural heart, electrophysiology, and diagnostic procedures. Laza Medical is a Shifamed portfolio company with additional investors including Unorthodox Ventures, PA MedTech, and AMED.
Generated from attributed reports · Updated 24 hours ago
Event evidence and corrections
0 attributed source owners. Ownership does not establish independent confirmation. Quantities are reported separately and are never added together.
No current evidence-backed claims. Missing information remains not reported.
Report timeline
Follow attributed reports and material updates.
- Robotics — Web news discoverySignalGE HealthCare invests $160 million in Laza Medical's AI-powered cath lab robotics
GE HealthCare led a $160 million financing round for Laza Medical, a startup developing an AI-powered robotic transesophageal echo (TEE) system for interventional cardiology. The investment will support development of the system designed to simplify procedures, increase autonomy, and improve access to therapies. The technology combines real-time 3D heart modeling, procedural guidance, and robotic probe control for structural heart, electrophysiology, and diagnostic procedures. Laza Medical is a Shifamed portfolio company with additional investors including Unorthodox Ventures, PA MedTech, and AMED.
Timezone · UTC
Article dates follow your selected timezone. Briefing editions use Hong Kong time (UTC+8).